This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Eosinophilic esophagitis
  • /
  • Diagnosis and Treatment of Eosinophilic Esophagiti...
Journal

Diagnosis and Treatment of Eosinophilic Esophagitis

Read time: 1 mins
Published:31st Dec 2017
Author: Straumann A, Katzka DA.
Availability: Pay for access, or by subscription
Ref.:Gastroenterology. 2018 Jan;154(2):346-359.
DOI:10.1053/j.gastro.2017.05.066
Diagnosis and Treatment of Eosinophilic Esophagitis


Eosinophilic esophagitis (EoE) is a new disease. It is caused by a T-helper type 2 cell response to food antigens in contact with the esophageal mucosa. Although no single feature defines EoE, a constellation of compatible demographic, clinical, endoscopic, and histologic findings establish the diagnosis. Children present with symptoms and endoscopic patterns characteristic of inflammation, whereas adolescents and adults have manifestations of fibrosis and gross esophageal strictures. Clinical and endoscopic scoring systems have helped to standardize diagnosis. There is controversy in EoE research over the optimal endpoint for treatment. Although the most common endpoint is a reduced number of eosinophils in biopsies, changes in symptoms and endoscopic features are becoming important targets of therapy. We should improve our understanding of EoE progression and the need for maintenance therapy, and continue development of diagnostic tools that avoid endoscopy and biopsy analyses to more easily monitor disease activity.


Read abstract on library site    Access full article